NCT07515690

Brief Summary

Chronic non-specific neck pain is a common musculoskeletal disorder that significantly affects quality of life and functional ability. Conventional treatments often provide limited relief and may be associated with adverse effects. Acupuncture and Chinese herbal fumigation are commonly used therapies in traditional Chinese medicine and have shown potential benefits in pain relief and functional recovery. This multicenter randomized controlled trial aims to evaluate the efficacy and safety of acupuncture combined with Chinese herbal fumigation in patients with chronic non-specific neck pain. A total of 120 participants will be randomly assigned to three groups: acupuncture combined with Chinese herbal fumigation, acupuncture combined with sham fumigation, and acupuncture alone. All participants will receive five treatment sessions within three weeks, followed by a four-week follow-up period. The primary outcome measure is pain intensity assessed using the Visual Analog Scale (VAS). Secondary outcome measures include the Neck Disability Index (NDI), cervical range of motion, Pittsburgh Sleep Quality Index (PSQI), quality of life scale, and Central Sensitization Inventory (CSI). This study aims to provide high-quality clinical evidence regarding the effectiveness of acupuncture combined with Chinese herbal fumigation for chronic non-specific neck pain.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
10mo left

Started May 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
May 2026Mar 2027

First Submitted

Initial submission to the registry

March 31, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 7, 2026

Completed
24 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2027

Expected
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

9 months

First QC Date

March 31, 2026

Last Update Submit

April 7, 2026

Conditions

Keywords

AcupunctureChinese herbal fumigationChronic neck painTraditional Chinese medicineRandomized controlled trial

Outcome Measures

Primary Outcomes (1)

  • Pain Intensity as Measured by the Visual Analog Scale

    The Visual Analog Scale is a 10 cm horizontal line ranging from 0 (no pain) to 10 (worst possible pain). Participants mark their current pain level on the line, and the distance in centimeters from the "no pain" end to the mark is recorded as the pain score.

    Baseline (T0), immediately after first treatment (T1), immediately after fifth treatment (T2), and at 4-week follow-up after final treatment (T3)

Secondary Outcomes (5)

  • Neck Disability Index

    Baseline (T0), immediately after first treatment (T1), immediately after fifth treatment (T2), and at 4-week follow-up after final treatment (T3)

  • Cervical Range of Motion

    Baseline (T0), after first treatment (T1), after fifth treatment (T2), and at 4-week follow-up (T3)

  • SF-36 Quality of Life Scale

    Baseline (T0), after fifth treatment (T2), and at 4-week follow-up (T3)

  • Pittsburgh Sleep Quality Index

    Baseline (T0), after fifth treatment (T2), and at 4-week follow-up (T3)

  • Central Sensitization Inventory

    Baseline (T0) and at 4-week follow-up (T3)

Study Arms (3)

Acupuncture Combined with Chinese Herbal Fumigation

EXPERIMENTAL

Participants receive acupuncture at bilateral cervical Jiaji points (EX-B2) combined with Chinese herbal fumigation using the Wenyang Tongluo Fumigation Formula. Five sessions over three weeks.

Other: AcupunctureOther: Wenyang Tongluo Fumigation Formula

Acupuncture Combined with Sham Fumigation

SHAM COMPARATOR

Participants receive acupuncture at bilateral cervical Jiaji points (EX-B2) combined with sham fumigation using pure water under identical temperature and duration conditions. Five sessions over three weeks.

Other: AcupunctureOther: Sham Fumigation

Acupuncture Alone

ACTIVE COMPARATOR

Participants receive acupuncture at bilateral cervical Jiaji points (EX-B2) alone. Five sessions over three weeks.

Other: Acupuncture

Interventions

A proprietary Chinese herbal formula (30 g herbal powder decocted with 1000 mL water) used for local neck fumigation. Temperature is controlled at 35°C for 3 minutes, then 40°C for 30 minutes. Steam outlet positioned 30 cm from the neck. Treatment is provided five times over three weeks.

Acupuncture Combined with Chinese Herbal Fumigation

Single-use sterile acupuncture needles (0.30 × 40 mm, Huatuo brand) are inserted at bilateral cervical Jiaji points (EX-B2). Needles are retained for 20 minutes with manipulation to achieve deqi. Treatment is provided five times over three weeks (approximately twice per week).

Acupuncture AloneAcupuncture Combined with Chinese Herbal FumigationAcupuncture Combined with Sham Fumigation

Pure water (1000 mL) is heated to produce steam for local neck fumigation under identical temperature and duration conditions as the active fumigation. Treatment is provided five times over three weeks.

Acupuncture Combined with Sham Fumigation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 to 65 years, any gender
  • Diagnosed with chronic non-specific neck pain lasting ≥ 3 months
  • Visual Analog Scale (VAS) pain score ≥ 4
  • Cervical range of motion reduced by ≥ 20% compared to normal range
  • Conformity to both Western diagnostic criteria and Traditional Chinese Medicine pattern differentiation for "cold coagulation type" neck pain
  • Voluntarily participate and provide signed informed consent

You may not qualify if:

  • Presence of confirmed cervical disc herniation, nerve compression, or other specific pathologies (e.g., infection, tumor, fracture, etc.)
  • History of cervical spine surgery or recent acute neck trauma
  • Concomitant severe systemic diseases (e.g., cardiovascular, hepatic, renal, hematological, or psychiatric disorders)
  • Pregnancy or breastfeeding
  • Known allergy to acupuncture needles or herbal fumigation components
  • Receipt of other neck pain-related treatments (e.g., physical therapy, medication, or acupuncture) within the past month
  • Presence of open wounds or skin lesions in the treatment area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Sungai Long Campus

Kajang, Selangor, 43000, Malaysia

Location

MeSH Terms

Interventions

Acupuncture Therapy

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Yang Mooi Lim, Prof. & Dr.

    M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Sungai Long Campus

    STUDY CHAIR
  • Chai Nien Foo, Phd

    M. Kandiah Faculty of Medicine and Health Sciences, Universiti Tunku Abdul Rahman, Sungai Long Campus

    STUDY DIRECTOR

Central Study Contacts

Jianying Gao, Phd

CONTACT

Yau Pin Yap, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Outcome assessors and data analysts are blinded to group allocation. Participants and acupuncturists are not blinded due to the nature of the fumigation intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Multicenter, randomized, parallel three-arm, assessor-blind controlled trial.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 31, 2026

First Posted

April 7, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be shared due to confidentiality agreements and the study protocol's data management provisions. Data will be used solely for research purposes by authorized research personnel and will not be publicly available. Reasonable requests for data access may be submitted to the corresponding author after study completion, subject to institutional approval.

Locations